ArticleMolecular oncology2021

Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors.

Paul van der Leest et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.